Cytarabine and Actos drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cytarabine and Actos. Common interactions include pneumonia among females and anaemia among males.
The phase IV clinical study analyzes what interactions people who take Cytarabine and Actos have. It is created by eHealthMe based on reports of 21 people who take Cytarabine and Actos from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
21 people who take Cytarabine and Actos together, and have interactions are studied.
What is Cytarabine?
Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 53,663 Cytarabine users for its effectiveness, alternative drugs and more.
What is Actos?
Actos has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 49,110 Actos users for its effectiveness, alternative drugs and more.
Number of Cytarabine and Actos reports submitted per year:

Common Cytarabine and Actos drug interactions by gender *:
female:
- Pneumonia
- Disease progression
- Pneumonia fungal
- Abdominal distension
- Acute myeloid leukaemia
- Acute respiratory distress syndrome
- Blood urea increased
- Bradycardia
- Cardiac arrest
- Cardiac failure
male:
- Anaemia
- Atrial fibrillation
- Supraventricular extrasystoles
- Blood glucose increased
- Blood urea increased
- Decreased appetite
- Electrocardiogram st-t change
- Left ventricular hypertrophy
- Platelet count decreased
- Respiratory failure
Common Cytarabine and Actos drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Abdominal distension
- Acute respiratory distress syndrome
- Blood urea increased
- Bradycardia
- Cardiac arrest
- Cardiac failure
- Cardiac failure chronic
- Fluid retention
- Hyperglycaemia
- Hypotension
60+:
- Pneumonia
- Anaemia
- Supraventricular extrasystoles
- Blood glucose increased
- Blood urea increased
- Decreased appetite
- Electrocardiogram st-t change
- Left ventricular hypertrophy
- Platelet count decreased
- Respiratory failure
Common conditions people have *:
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 14 people, 66.67%
- Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 33.33%
- Iron Overload: 4 people, 19.05%
- Enlarged Prostate: 4 people, 19.05%
- Erection Problems: 4 people, 19.05%
- Sleep Disorder: 4 people, 19.05%
- Pain: 4 people, 19.05%
- Indigestion: 4 people, 19.05%
- Liver Disorder (liver diseases): 3 people, 14.29%
- Gastritis (inflammation of stomach): 3 people, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Cytarabine and Actos?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Cytarabine (53,663 reports)
- Actos (49,110 reports)
Browse all drug interactions of Cytarabine and Actos:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Cytarabine side effects:
- Thrombocytopenia (decrease of platelets in blood): 4,354 reports
- Fever: 4,257 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3,682 reports
- Sepsis (a severe blood infection that can lead to organ failure and death): 3,322 reports
- Pneumonia: 2,580 reports
- Hypotension (abnormally low blood pressure): 2,000 reports
- Septic shock (shock due to blood infection): 1,896 reports
Browse all side effects of Cytarabine:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Actos side effects:
- Bladder cancer: 9,563 reports
- Weight decreased: 2,509 reports
- Weight increased: 2,205 reports
- Breathing difficulty: 2,144 reports
- Weakness: 1,950 reports
- Diarrhea: 1,894 reports
Browse all side effects of Actos:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Cytarabine interactions:
- Cytarabine and Methotrexate: 22,815 reports
- Cytarabine and Cyclophosphamide: 18,102 reports
- Cytarabine and Etoposide: 14,215 reports
- Cytarabine and Prednisone: 8,003 reports
- Cytarabine and Vincristine sulfate: 6,609 reports
- Cytarabine and Mercaptopurine: 6,210 reports
- Cytarabine and Dexamethasone: 5,922 reports
- Cytarabine and Fludara: 4,929 reports
- Cytarabine and Cisplatin: 4,837 reports
- Cytarabine and Prednisolone: 4,556 reports
Browse all interactions between Cytarabine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Actos interactions:
- Actos and Metformin: 11,292 reports
- Actos and Byetta: 5,322 reports
- Actos and Aspirin: 5,139 reports
- Actos and Glucophage: 5,033 reports
- Actos and Lipitor: 4,914 reports
- Actos and Lantus: 4,463 reports
- Actos and Amaryl: 4,289 reports
- Actos and Lisinopril: 3,960 reports
- Actos and Januvia: 3,471 reports
- Actos and Lasix: 3,095 reports
Browse all interactions between Actos and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cytarabine and pioglitazone hydrochloride (the active ingredients of Cytarabine and Actos, respectively), and Cytarabine and Actos (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cytarabine and Actos.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Acetaminophen and Placenta Praevia - a second ago
- Glyburide and Hepatitis - a second ago
- Bystolic and Keppra drug interaction - 4 seconds ago
- Oleptro and Diarrhea Aggravated - 8 seconds ago
- Metronidazole and Keppra drug interaction - 8 seconds ago
- Cisplatin and Keppra drug interaction - 9 seconds ago
- Etoposide and Keppra drug interaction - 9 seconds ago
- Ambien and Keppra drug interaction - 9 seconds ago
- Fish Oil and Trigger Finger - 11 seconds ago
- Co-Codamol and Insomnia - 12 seconds ago